Abstract
The Cambridge Healthtech Institute (CHI) continued its annual Discovery on Target series of conferences as a virtual platform due to the COVID-19 pandemic preventing live attendance at large events This, the 18th annual conference, continued the multitrack format, providing coverage of a wide range of targeting topics, including RNA, PROTACs, antibodies, proteins, immunology and oncology, nonalcoholic steatohepatitis, fibrosis, models, cell/gene therapy, kinase inhibitor and GPCR-based drug discovery, biomarkers Along with live and on-demand presentations, all with potential for QAa virtual exhibit hall was also created This report will cover some of the presentations given relating to drug discovery and potential targets Copyright © 2020 Clarivate Analytics
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
